Brief: Orexo Secures Patent Protection In U.S. For Ox640
29/08/2023 07:21
Aug 29 (Reuters) - Orexo AB ORX.ST :
* SECURES PATENT PROTECTION IN US FOR OX640, A NASAL
EPINEPHRINE
POWDER PRODUCT
Source text for Eikon: ID:nWkr8Lm5v5
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens